Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial

SIMPLE SUMMARY: Intensified neoadjuvant treatment in rectal cancer can enhance tumor regression and improve survival. However, treatment-related side effects can compromise the success of these treatments by leading to premature discontinuation of therapy. We developed and validated a predictive mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Diefenhardt, Markus, Martin, Daniel, Ludmir, Ethan B., Fleischmann, Maximilian, Hofheinz, Ralf-Dieter, Ghadimi, Michael, Kosmala, Rebekka, Polat, Bülent, Friede, Tim, Minsky, Bruce D., Rödel, Claus, Fokas, Emmanouil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497244/
https://www.ncbi.nlm.nih.gov/pubmed/36139585
http://dx.doi.org/10.3390/cancers14184425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497244/
https://www.ncbi.nlm.nih.gov/pubmed/36139585
http://dx.doi.org/10.3390/cancers14184425

Ejemplares similares